期刊文献+

组蛋白修饰影响肿瘤血管生成的研究进展 被引量:2

Research progress of histone modification and tumor angiogenesis
下载PDF
导出
摘要 组蛋白修饰是表观遗传调控的一种重要方式,它通过相关修饰酶发生翻译后修饰从而改变染色质的结构和功能。肿瘤血管生成是肿瘤发生、发展、转移、复发过程中至关重要的一个环节。已有大量研究发现,组蛋白修饰和肿瘤血管生成有着密切联系,组蛋白修饰酶可以改变自身表达量或者直接作用于癌基因,也可以与热休克蛋白等相互作用促进或抑制肿瘤血管生成并在一定程度上影响肿瘤的预后。本文就组蛋白修饰在肿瘤血管生成方面的最新研究展开综述,以期揭示组蛋白修饰在其中的具体作用机制、分子机理并为肿瘤预防、诊断、治疗、预后提供新方向。 Histone modification plays an important role in epigenetics.It changes the structure and function of chromatin by post-translational modification via related modification enzymes.Tumor angiogenesis is a crucial link in the process of tumor development,metastasis and recurrence.A large number of studies have found that histone modification is closely related to tumor angiogenesis.Histone modification enzymes can change their own expression or act directly on onco⁃genes,or interact with heat shock proteins to promote or inhibit tumor angiogenesis and affect the prognosis of tumors to a certain extent.In this paper,the latest research on histone modification in tumor angiogenesis is reviewed,so as to reveal the specific mechanism and molecular mechanism of histone modification in tumor angiogenesis and provide a new direction for tumor prevention,diagnosis,treatment and prognosis.
作者 胡昂 刘宇文 赖仲宏 张弥 胡泽明 钟佳宁 HU Ang;LIU Yu-wen;LAI Zhong-hong;ZHANG Mi;HU Ze-ming;ZHONG Jia-ning(Gannan Medical University,Jiangxi Ganzhou 341000;Department of Gnenral Surgrey,The First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangshu 210000;Key Laboratory of Ministry of Education for Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases,Gannan Medical University,Ganzhou,Jiangxi 341000)
出处 《赣南医学院学报》 2022年第1期16-23,共8页 JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金 国家自然科学基金资助项目(82060363,81760160) 江西省大学生创新创业训练计划项目(202010413002,S202010413009) 赣南医学院校级课题(BKSZR201902)。
关键词 表观遗传学 组蛋白修饰 甲基化 乙酰化 肿瘤血管生成 Epigenetics Histone modification Methylation Acetylation Tumor angiogenesis
  • 相关文献

参考文献11

二级参考文献72

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1367
  • 2田筱青,房静远.组蛋白甲基化研究进展[J].生物化学与生物物理进展,2006,33(6):511-516. 被引量:13
  • 3刘飞,靳飞,翟晓巧,贾峰.组蛋白甲基化和去甲基化研究进展[J].中国农学通报,2007,23(2):56-59. 被引量:4
  • 4Rikimaru T,Taketomi A,Yamashita Y,et al.Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma[J].Oncology,2007,72 (1/2):69-74.
  • 5Zhang Y,Fang H,Jiao J,et al.The structure and function of histone deacetylases:the target for anti-cancer therapy[J].Curr Med Chem,2008,15(27):2840-2849.
  • 6Miano J M,Berk B C.HDAC7 supports vascular integrity[J].Nat Med,2006,12 (9):997-998.
  • 7Ouassi M,Sielezneff I,Silvestre R,et al.High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas[J].Ann Surg Oncol,2008,15(8):2318-2328.
  • 8Duong V,Bret C,Altucci L,et al.Specific activity of class II histone deacetylases in human breast cancer cells[J].Mol Cancer Res,2008,6(12):1908-1919.
  • 9Bakin R E,Jung M O.Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis[J].J Biol Chem,2004,279 (49):51218-51225.
  • 10Dokmanovic M,Perez G,Xu W.Histone deacetylase inhibitors selectively uppress expression of HDAC7[J].Mol Cancer Ther,2007,6 (9):2525-2534.

共引文献227

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部